Worldwide Pharmaceuticals to 2021: Drifting Towards Big Data & Analytics – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Pharmaceuticals:
Drifting towards Big Data & Analytics – Drivers, challenges and
technology developments”
report has been added to ResearchAndMarkets.com’s
offering.

Pharmaceuticals: Drifting towards Big Data & Analytics
is an attempt to analyze the key trends expected to impact the
Pharmaceuticals industry and its various stakeholders in 2018.

Although the adoption of big data in pharmaceutical operations has been
focused mostly on R&D, vendors are exploring its potential use in other
operational processes. In supply chain, it helps pharmaceutical
companies diagnose issues in their logistics, supplier performance,
procurement, delays in delivery, demand management, etc. Vendors are
launching BDA solutions that focus on increasing supply chain
productivity of pharmaceutical companies.

With competition increasing in the pharmaceutical sector and the market
flooded with a multitude of treatments and therapies, determining drug
efficacy and designing market strategies remains a priority, while
maintaining drug safety. The use of big data in these operational
domains will enable pharmaceutical companies to introduce innovations in
both products and processes. With digital transformation being the main
priority of most pharmaceutical enterprises, the adoption of BDA and AI
platforms are expected to increase in the coming years.

Scope

  • Overview of the technology and its relevance in the verticals.
  • Key challenges faced by the industry verticals (pharmaceutical)
    pertinent to its technology (big data & analytics) implementation.
  • Elaborate overview of supply side and demand side trends affecting the
    technology growth.
  • Overview of the revenue opportunities in the big data & analytics
    market for the pharmaceutical sector through to 2021 – highlighting
    the market size and growth by technology, geography, sectors, and size
    band. Moreover, the report also outlines enterprises’ investment
    priorities in the big data & analytics segment for the pharmaceutical
    sector.
  • Future recommendation and market opportunities for big data &
    analytics segment in the pharmaceutical industry.

Reasons to Buy

  • Helps the reader to understand the big data & analytics market
    landscape in the pharmaceutical industry, the recent trends, and
    challenges.
  • The most exhaustive and up-to-date report providing revenue
    opportunity forecasts in the big data & analytics market from 2016 to
    2021, spanning four technology segments, six regions, and two size
    bands.
  • Extensive technology growth predictions based on adoption indicators,
    end-user technology demand, ICT survey results, and macroeconomic
    factors.
  • The report provides a detailed breakdown of the opportunities within
    the big data & analytics segment and its sub categories.

Topics Covered

1 Introduction

2 Challenges Impacting Pharmaceuticals in Big Data Analytics

3 Market Dynamics

4 BI Investment Priorities in the Pharmaceutical Sector

5 Market Size and Forecast

6 Recommendations

7 Future Outlook

For more information about this report visit https://www.researchandmarkets.com/research/bc5jqg/worldwide?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Big
Data
, Data
Analytics